Keyword results: CIR

Bearcast
PREMIUM CONTENT

Tom Winnifrith Bearcast: hat tip to Jim Mellon & Henry Freeman gets a blast for his Godless nonsense

FFS it is not Season's Greetings but Happy Christmas. Please do not wind me up with any more Godless messages. Thanks to Jim for flagging up what should be a parody, but sadly is not, Neil Woodford's next business venmture. The I look at Bidstack (BIDS), NMC Health (NMC) and Circassia (CIR), two of which are surely good bets for bankruptcy in 2020. 

Subscribe to ShareProphets to access Premium Content
Bearcast
PREMIUM CONTENT

Tom Winnifrith Bearcast: Recording with an audience but I can't tell you why

All will be revealed soon. Meanwhile I discuss Eddie Stobart (ESL), Circassia (CIR), Thomas Cook (TCG), Amur Minerals (AMC), Neil Woodford and Watchstone Group (WTG), Quindell as was.

Subscribe to ShareProphets to access Premium Content
CIR
CIR

Neil Woodford favourite Circassia – IP Group is selling

Oh dear! It appears from a TR-1 released by Circassia Pharmaceuticals (CIR) today as though IP Group (IPO) - a Woodford investee - has been selling shares in Circassia, a favourite of Neil Woodford...

IPO
IPO
PREMIUM CONTENT

IP Group – is there a read-across to Neil Woodford?

Fully-listed IP Group (IPO) is an investment company which throws money at early-stage companies. At the last count (28 Feb 2019) Woodford’s Equity Income Fund (EIF) was 3% invested. The remit sounds fairly close to that of WPCT – and many companies are indeed the same, as pointed out in previous ShareProphets articles.

Subscribe to ShareProphets to access Premium Content
Bearcast
PREMIUM CONTENT

Tom Winnifrith Bearcast: a tale of two Morons - Craig the IOG shareholder and a chap called Neil

In today's bearcast I have a hot rumour about Neil Woodford and I look at a moron called Craig who owns shares in Independent Oil & Gas (IOG) and is a classic moron. I look at that company at Circassia (CIR) - a Woodford dog - and at Gear4Music (G4M). Tomorrow I take my family and my son Joshua's godfather Lucian Miers to the London Stadium to see mighty West Ham in the cup so I'm not sure when Saturday copy will arrive.

Subscribe to ShareProphets to access Premium Content
CIR
CIR

FCA short positions table: more bad news for Woodford ahead?

I have been taking a look through the FCA table of registered short positions, following my piece on Interserve of Friday. I don’t offer anything exhaustive, but the largest individual short positions interested me as they are as high as 5.42% of the capital. That’s quite a bet. Oh, and just as it happens, Neil Woodford features with two of them. They are also all stocks where we at ShareProphets have been bearish.

CIR
CIR

Does Neil Woodford really deserve a halo - is Circassia the biggest dog in his funds?

If you read the bent, freebie is our middle name, personal financie columnists in the deadwood press, fund manager Neil Woodford walks on water. I disagree and have noted before, that, maybe, after three dismal years, others are starting to see the light.  But, with assistance from a leading broker, how about we have a real look at the Woodford Patient Capital Trust (WPCT) but also at the sort of dogs Neil ifalls in love with.

Bearcast

Tom Winnifrith Bearcast: Drown all cat haters including my brother in law

I am back in from the fields where I have been labouring in 40 degree plus heat. Today I offer a few thoughts on Circassia (CIR) and the risks folks just dont seem to appreciate of a) biotech and b) backing stock selections of star fund managers, in this case Neil Woodford - who incidentally is clearly a very talented chap. I look at Gulf Keystone (GKP), XCite Energy (XEL), China Frauds and then in some detail at Blur (BLUR). For further info on its brain dead dickhead of a PR man Dominic Barretto go HERE

CIR
CIR

Circassia shares crash on cat trial failure - the latest Neil Woodford Biotech disaster

Hats off to veteran journalist Tim Blackstone who called Circassia (CIR) as a short with a £900 million market cap on January 16 this year HERE. Today the shares have crashed by 64% to 98.5p giving it a market cap of just £261 million. Tim Blackstone dared to go up against Neil Woodford with this call as he is the largest shareholder. It looks like another biotech disaster for Woodie. 

CIR
CIR

Letting the Cat Out of the Bag: Circassia is a short

In the mid nineties the flagship of UK biotech was British Biotech a constituent of the FTSE 100 share index with a valuation of £1.5 billion. The company enjoyed the support of the leading healthcare analyst, Dr Ian White, and rode high on a supposed inhibitor for cancer called marimastat. In my swansong as a financial journalist I wrote a devastating critique in the Mail on Sunday in the summer of 1996 with on the record quotes from leading oncologists in Edinburgh and London. Subsequent investigations on both sides of the Atlantic found that the company “had wilfully misled the public about the progress of marimastat”. British Biotech collapsed.

Red Flags at Night: Plus 500 takeover delay and Circassia Pharma NED selling

Two no-one-is-watching o’clock RNSs caught my eye last night, both after 6pm when everyone had gone home for the weekend, or perhaps were limbering up for the opening skirmishes of the Rugby World Cup. One from fully-listed Circassia Pharmaceuticals plc (CIR), and the other involved the much covered AIM-listed Plus 500 (PLUS) and its proposed takeover by fully listed Playtech (PTEC).

CIR
CIR

Zak Mir's Bull Call Of The Day No. 2: Circassian Pharma: Support At 200 Day Line Implies Upside To 400p

Circassia Pharma (CIR) may not be a company name most are familiar with, but at least from a technical perspective its shares have had an overall constructive setup over recent months. I now provide an upside share price target.

Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Complete Coverage

Recent Comments

|